To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C21orf33TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
563 supporting clones for gene C21orf33 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG747198 adenocarcinoma cell line, colon .a 1 to 811 1 to 808   tiling clone,   810/814
(99 %)
16 diff
(98.1 %id)
TI_57198001   .a 29 to 726 63 to 761       699/761
(91 %)
9 diff
(98.9 %id)
BI821172 pooled brain, lung, testis .a 33 to 726 1 to 695       695/695
(100 %)
9 diff
(98.8 %id)
BX458740 placenta .a 66 to 1209 1 to 1134   tiling clone,   1134/1139
(99 %)
17 diff
(98.6 %id)
BI116363 lung, small cell carcinoma .a 420 to 1023 1 to 606   tiling clone,   606/1024
(59 %)
9 diff
(99.2 %id)
BF980962 duodenal adenocarcinoma, cell line, small intestine .b 1 to 769 1 to 779       779/833
(93 %)
27 diff
(96.8 %id)
BP283346 bone marrow .b 8 to 589 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
NM_004649.6   .b 8 to 1675 1 to 1668 V6A RefSeq,   1668/1668
(100 %)
2 diff
(99.9 %id)
CN291933 embryonic stem cells, cell lines H1, H7, andH9 .b 10 to 655 1 to 646       646/646
(100 %)
5 diff
(99.3 %id)
TI_57196562   .b 10 to 761 21 to 770       750/770
(97 %)
13 diff
(98.4 %id)
U53003   .b 10 to 1661 1 to 1652 V6A     1652/1652
(100 %)
2 diff
(99.9 %id)
BF307711 muscle, rhabdomyosarcoma .b 11 to 683 1 to 676       642/929
(69 %)
12 diff
(98.8 %id)
BG473487 eye, retinoblastoma .b 11 to 610 1 to 611       611/611
(100 %)
27 diff
(95.6 %id)
TI_57240307   .b 12 to 871 31 to 897       867/902
(96 %)
20 diff
(97.8 %id)
BX401043   .b 13 to 771 1 to 760       760/760
(100 %)
6 diff
(99.3 %id)
CF141136 CNCAP(3)T-225 cell line, Prostate .b 13 to 267 8 to 262       255/262
(97 %)
7 diff
(97.4 %id)
BQ642298 lymph, lymphoma, cell line .b 13 to 532 80 to 602       523/1241
(42 %)
21 diff
(98.4 %id)
BQ961568 leiomyosarcoma, uterus .b 14 to 824 1 to 817       817/886
(92 %)
15 diff
(98.4 %id)
BQ056321 lymph, lymphoma, cell line .b 15 to 986 1 to 988 E224G V225S V226G E227R A228S ...     988/1002
(98 %)
37 diff
(96.4 %id)
BU859370 ovary, teratocarcinoma, cell line .b 15 to 614 1 to 600       600/950
(63 %)
5 diff
(99.5 %id)
TI_57164748   .b 15 to 811 24 to 820       797/821
(97 %)
15 diff
(98.2 %id)
AL515753 brain, neuroblastoma, neuroblastoma cells .b 16 to 1005 1 to 983 A33P L34F H35T L36S S37P ... fully sequenced,   983/983
(100 %)
6 diff
(99.4 %id)
AL517916 brain, neuroblastoma, neuroblastoma cells .b 16 to 950 1 to 923 A33X L34F H35T L36S S37P ... fully sequenced, AAA   923/923
(100 %)
5 diff
(99.5 %id)
BX457896 neuroblastoma .b 16 to 771 1 to 755       755/755
(100 %)
4 diff
(99.5 %id)
BE889707 leiomyosarcoma, uterus .b 16 to 525 17 to 529       513/533
(96 %)
13 diff
(97.6 %id)
CD171762 testis .b 16 to 780 23 to 795       773/923
(83 %)
25 diff
(97.3 %id)
BI818655 pooled brain, lung, testis .b 17 to 761 1 to 743       743/743
(100 %)
8 diff
(99.0 %id)
BI913345 brain .b 19 to 871 1 to 860       860/865
(99 %)
15 diff
(98.3 %id)
BQ640674 eye, retina .b 22 to 935 1 to 596 V6A E62Q S64G A65K I66P ...     596/596
(100 %)
2 diff
(99.7 %id)
BU183813 melanotic melanoma, skin .b 22 to 753 15 to 753       739/882
(83 %)
23 diff
(97.4 %id)
TI_57186264   .b 22 to 639 52 to 670       619/619
(100 %)
5 diff
(99.2 %id)
BC002370 Lung, small cell carcinoma .b 23 to 1661 1 to 1639 V6A tiling clone, available from MGC, AAA   1639/1639
(100 %)
3 diff
(99.9 %id)
CR626372 neuroblastoma .b 23 to 1629 1 to 1607 exact     1607/1607
(100 %)
0 diff
(100 %id)
AL518349 brain, neuroblastoma, neuroblastoma cells .b 23 to 855 1 to 828   fully sequenced, AAA   828/828
(100 %)
10 diff
(98.8 %id)
AL539642 brain, fetal brain .b 23 to 881 1 to 857   fully sequenced,   857/857
(100 %)
3 diff
(99.7 %id)
AL545457 placenta, Placenta Cot 25-normalized .b 23 to 771 1 to 749       749/749
(100 %)
8 diff
(99.0 %id)
AW250722 lung, small cell carcinoma .b 23 to 543 10 to 530       521/530
(98 %)
6 diff
(98.9 %id)
BI763533 pooled colon, kidney, stomach .b 23 to 746 1 to 727       727/727
(100 %)
7 diff
(99.1 %id)
BI754023 brain .b 23 to 813 1 to 791       791/791
(100 %)
10 diff
(98.8 %id)
BI835342 pooled pancreas and spleen .b 23 to 811 1 to 789       789/790
(99 %)
13 diff
(98.4 %id)
BI833844 pooled pancreas and spleen .b 23 to 742 1 to 730       730/734
(99 %)
20 diff
(97.3 %id)
BI855634 breast, mammary adenocarcinoma, cell line .b 23 to 639 1 to 618       618/618
(100 %)
5 diff
(99.2 %id)
BQ940207 sciatic nerve .b 23 to 631 22 to 632       611/929
(65 %)
18 diff
(98.1 %id)
TI_57218902   .b 23 to 813 34 to 824       791/824
(95 %)
15 diff
(98.2 %id)
TI_57152179   .b 23 to 746 35 to 761       727/761
(95 %)
8 diff
(99.0 %id)
TI_57166936   .b 23 to 742 37 to 766       695/770
(90 %)
19 diff
(97.6 %id)
BG025400 lymph, lymphoma, cell line .b 24 to 704 1 to 686       686/687
(99 %)
21 diff
(97.0 %id)
BG255520 adenocarcinoma, cell line, Prostate .b 24 to 771 1 to 745       745/758
(98 %)
26 diff
(96.6 %id)
BM450958 eye, retinoblastoma .b 24 to 689 1 to 666       666/971
(68 %)
19 diff
(98.1 %id)
BM918101 blood, natural killer cells, cell line .b 25 to 595 1 to 570       570/1110
(51 %)
16 diff
(98.6 %id)
CN291944 embryonic stem cells, DMSO-treated H9 cellline .b 26 to 581 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
Y07572   .b 26 to 1674 1 to 1648 V6A I213M     1648/1649
(99 %)
5 diff
(99.7 %id)
BG767521 melanotic melanoma, high MDR (cell line), skin .b 27 to 585 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
BQ072013 brain, neuroblastoma, cell line .b 27 to 951 1 to 933 V6A G208R E211K V225K V226G ...     933/1001
(93 %)
45 diff
(95.6 %id)
BP245684 Kidney .b 30 to 612 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BI094258 cervix .b 32 to 761 1 to 731       731/736
(99 %)
9 diff
(98.8 %id)
BQ943501 large cell carcinoma, lung .b 34 to 967 1 to 940 V6A A184X E227X D231E V237G ...     940/941
(99 %)
17 diff
(98.2 %id)
BE547945 cervical carcinoma cell line, cervix .b 35 to 769 1 to 726       726/727
(99 %)
28 diff
(96.2 %id)
BQ188414 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 37 to 506 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
BF219997 lung, small cell carcinoma .b 42 to 765 1 to 715       715/762
(93 %)
23 diff
(97.0 %id)
AL515360 neuroblastoma, placenta .b 43 to 870 1 to 825   fully sequenced,   825/825
(100 %)
5 diff
(99.4 %id)
CR597695 Neuroblastoma Cot 25-normalized .b 43 to 1656 1 to 1614 exact     1614/1614
(100 %)
0 diff
(100 %id)
BX353477 Neuroblastoma Cot 25-normalized .b 43 to 875 1 to 832   fully sequenced,   832/832
(100 %)
2 diff
(99.8 %id)
BE869624 adenocarcinoma, colon .b 43 to 846 1 to 795       795/910
(87 %)
32 diff
(96.5 %id)
BM017516 astrocytoma grade IV, cell line, brain .b 43 to 613 1 to 575       575/955
(60 %)
14 diff
(98.6 %id)
CX784795 human embryonic stem cells .b 43 to 858 1 to 816       816/816
(100 %)
1 diff
(99.9 %id)
BE783229 eye, retinoblastoma .b 44 to 656 1 to 612       612/612
(100 %)
4 diff
(99.4 %id)
BQ055306 lymph, lymphoma, cell line .b 44 to 758 23 to 743       721/1178
(61 %)
17 diff
(98.6 %id)
TI_59388018   .b 44 to 613 116 to 689       574/954
(60 %)
13 diff
(98.7 %id)
BG482137 choriocarcinoma, placenta .b 45 to 767 1 to 729       729/975
(74 %)
17 diff
(98.3 %id)
CR621591 neuroblastoma .b 46 to 1636 1 to 1591 exact     1591/1591
(100 %)
0 diff
(100 %id)
BE547450 cervical carcinoma cell line, cervix .b 46 to 730 1 to 683       683/683
(100 %)
7 diff
(99.0 %id)
BG385574 adenocarcinoma cell line, colon .b 46 to 577 1 to 532       532/532
(100 %)
4 diff
(99.3 %id)
BM468774 embryonal carcinoma, cell line, testis .b 47 to 1027 1 to 985 V6A G217X K233X A257S R260K ...     985/996
(98 %)
21 diff
(97.9 %id)
CV814950 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 47 to 522 1 to 476       476/818
(58 %)
12 diff
(98.6 %id)
BI915511 brain .b 48 to 611 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
BI915519 brain .b 48 to 849 1 to 799       799/800
(99 %)
6 diff
(99.3 %id)
BQ231198 melanotic melanoma, skin .b 48 to 885 1 to 850       850/854
(99 %)
18 diff
(97.9 %id)
BU194620 melanotic melanoma, cell line, skin .b 48 to 531 117 to 611       495/1019
(48 %)
34 diff
(96.7 %id)
BU196224 melanotic melanoma, cell line, skin .b 48 to 519 117 to 590       474/930
(50 %)
18 diff
(98.1 %id)
BU180004 melanotic melanoma, cell line, skin .b 48 to 660 143 to 758       614/1011
(60 %)
15 diff
(98.6 %id)
BQ682099 melanotic melanoma, cell line, skin .b 48 to 743 117 to 829       713/935
(76 %)
34 diff
(96.4 %id)
BQ682306 melanotic melanoma, cell line, skin .b 48 to 739 117 to 812       696/934
(74 %)
23 diff
(97.6 %id)
BQ675996 melanotic melanoma, cell line, skin .b 48 to 625 117 to 694       578/989
(58 %)
23 diff
(97.7 %id)
BQ683843 melanotic melanoma, cell line, skin .b 48 to 772 129 to 854       726/933
(77 %)
14 diff
(98.5 %id)
TI_57239238   .b 48 to 611 31 to 593       563/593
(94 %)
6 diff
(99.0 %id)
TI_57239246   .b 48 to 849 61 to 859       799/860
(92 %)
10 diff
(98.9 %id)
BE389224 endometrium, adenocarcinoma cell line, uterus .b 64 to 700 1 to 640       638/640
(99 %)
7 diff
(99.0 %id)
BE389200 endometrium, adenocarcinoma cell line, uterus .b 64 to 663 1 to 597       597/598
(99 %)
11 diff
(98.2 %id)
BU557869 adenocarcinoma, cell line, breast .b 65 to 1010 1 to 949 V6A M243L M258L     949/949
(100 %)
16 diff
(98.4 %id)
BE271856 adenocarcinoma cell line, ovary .b 66 to 748 1 to 675       675/778
(86 %)
23 diff
(97.1 %id)
BE903113 choriocarcinoma, placenta .b 67 to 815 1 to 745       745/896
(83 %)
14 diff
(98.5 %id)
BM927458 lymph, lymphoma, cell line .b 67 to 848 1 to 785       785/1108
(70 %)
8 diff
(99.3 %id)
BQ642731 lymph, lymphoma, cell line .b 67 to 968 1 to 905 H252P D253*     905/905
(100 %)
6 diff
(99.4 %id)
AL516824 brain, neuroblastoma, neuroblastoma cells .b 69 to 878 1 to 801   fully sequenced,   801/801
(100 %)
8 diff
(99.1 %id)
BX419378 brain, fetal brain .b 69 to 1031 1 to 960 V6A A33X L34F H35T L36S ...     960/960
(100 %)
4 diff
(99.6 %id)
TI_57164584   .b 69 to 742 21 to 694       674/694
(97 %)
6 diff
(99.2 %id)
BU558295 adenocarcinoma, cell line, breast .b 70 to 930 1 to 874 V6A A43D A184D E191Q Q198H ...     874/877
(99 %)
31 diff
(96.5 %id)
BU558296 adenocarcinoma, cell line, breast .b 70 to 946 1 to 882 V6A V236W V237S T238R T239P ...     882/882
(100 %)
9 diff
(99.0 %id)
BX446635 neuroblastoma .b 71 to 1091 26 to 1037 A33P L34F H35T L36S S37P ... AAA   1012/1095
(92 %)
20 diff
(98.2 %id)
CD251215 brain, Pituitary .b 71 to 868 20 to 817       798/867
(92 %)
10 diff
(98.9 %id)
CF122906 CNCAP(3)T-225 cell line, Prostate .b 71 to 629 8 to 566       559/566
(98 %)
6 diff
(99.0 %id)
TI_57182502   .b 71 to 698 22 to 648       627/648
(96 %)
7 diff
(99.0 %id)
TI_154182628   .b 71 to 771 69 to 771       703/836
(84 %)
11 diff
(98.7 %id)
AW245554 lung, small cell carcinoma .b 72 to 531 11 to 470       460/470
(97 %)
6 diff
(98.8 %id)
AL574334 placenta, Placenta Cot 25-normalized .b 76 to 949 1 to 871 V4F R5M V6A G25R R26S ... fully sequenced,   871/871
(100 %)
10 diff
(98.9 %id)
TI_57150741   .b 76 to 1044 25 to 998 V6A V45S A46R L47W V48C ...     974/1001
(97 %)
27 diff
(97.4 %id)
BC003587 Lung, small cell carcinoma .b 77 to 1661 1 to 1586 V6A available from MGC, AAA   1586/1586
(100 %)
3 diff
(99.9 %id)
CN291941 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 77 to 735 9 to 668       660/668
(98 %)
2 diff
(99.8 %id)
D86061 brain .b 77 to 1659 1 to 1583 V6A     1583/1583
(100 %)
3 diff
(99.9 %id)
BI834108 pooled pancreas and spleen .b 77 to 742 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
BI769482 pooled lung and spleen .b 78 to 698 1 to 620       620/620
(100 %)
3 diff
(99.6 %id)
BQ439254 embryonal carcinoma, cell line, testis .b 78 to 1051 1 to 982 V6A H252P D253*     982/1097
(89 %)
33 diff
(97.0 %id)
BX362490   .b 79 to 982 1 to 901 V6A A33X L34F H35T L36S ...     901/901
(100 %)
4 diff
(99.6 %id)
BX386640   .b 79 to 1163 1 to 1079 V6A A33X L34F H35T L36S ... AAA   1079/1079
(100 %)
19 diff
(98.3 %id)
BX444063 fetal liver, Liver .b 79 to 929 1 to 850 V6A L34F H35N L36S S37P ... fully sequenced,   850/850
(100 %)
32 diff
(96.3 %id)
BM918291 blood, natural killer cells, cell line .b 79 to 789 23 to 734       712/1094
(65 %)
23 diff
(97.9 %id)
DB477314 hippocampus .b 81 to 578 1 to 498       498/498
(100 %)
3 diff
(99.4 %id)
CN291935 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 82 to 257 10 to 185       176/185
(95 %)
7 diff
(96.3 %id)
BI911255 leukocyte .b 82 to 980 1 to 899 V45S A46R L47W V48C L49C ...     899/899
(100 %)
14 diff
(98.5 %id)
BQ881630 brain, neuroblastoma, cell line .b 82 to 609 1 to 535       535/809
(66 %)
19 diff
(97.7 %id)
BQ932672 brain, neuroblastoma, cell line .b 82 to 966 1 to 890 V6A G217X K261X     890/899
(98 %)
10 diff
(98.9 %id)
TI_57232045   .b 82 to 980 1 to 899 V45S A46R L47W V48C L49C ...     899/899
(100 %)
14 diff
(98.5 %id)
BM763835 myeloma .b 82 to 641 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
TI_57198726   .b 83 to 688 22 to 627       606/627
(96 %)
6 diff
(99.1 %id)
BG476882 melanotic melanoma, skin .b 84 to 871 1 to 797       797/802
(99 %)
22 diff
(97.3 %id)
BG479071 choriocarcinoma, placenta .b 84 to 849 1 to 771       771/771
(100 %)
14 diff
(98.2 %id)
BF526710 brain, glioblastoma with EGFR amplification .b 85 to 872 1 to 785       785/788
(99 %)
9 diff
(98.9 %id)
BI762693 pooled colon, kidney, stomach .b 85 to 1044 1 to 966 V6A V45S A46R L47W V48C ...     966/969
(99 %)
24 diff
(97.6 %id)
BG468928 adenocarcinoma cell line, colon .b 88 to 790 1 to 702       702/702
(100 %)
11 diff
(98.5 %id)
BQ052196 blood, natural killer cells, cell line .b 88 to 1070 1 to 1000 L263P E264G L265T T266P G267W     1000/1057
(94 %)
35 diff
(96.7 %id)
BQ896291 eye, normal pigmented retinal epithelium .b 88 to 942 1 to 866 A3G V4C R5E V6G L7P ...     866/867
(99 %)
19 diff
(97.9 %id)
BQ935748 carcinoma, cell line, Prostate .b 88 to 959 1 to 881 V6A E224G V225S V226G E227R ...     881/946
(93 %)
16 diff
(98.4 %id)
BQ958431 carcinoma, cell line, Prostate .b 88 to 946 1 to 867 V6A Q232H G254A G256R M258L ...     867/951
(91 %)
24 diff
(97.5 %id)
TI_57196232   .b 88 to 849 27 to 789       763/790
(96 %)
11 diff
(98.7 %id)
DN995042 brain, whole brain .b 88 to 713 8 to 633       626/633
(98 %)
7 diff
(98.9 %id)
CR599538 Placenta Cot 25-normalized .b 89 to 1632 1 to 1544 exact     1544/1544
(100 %)
0 diff
(100 %id)
BX357484 Placenta Cot 25-normalized .b 89 to 872 1 to 781   fully sequenced,   781/781
(100 %)
3 diff
(99.7 %id)
BX359361 Placenta Cot 25-normalized .b 89 to 996 1 to 905 V6A A33P L34F H35T L36S ... fully sequenced,   905/905
(100 %)
4 diff
(99.6 %id)
AL558717 T cells from T cell leukemia .b 89 to 947 1 to 859 V6X A33P L34S H35P S37R ... fully sequenced,   859/859
(100 %)
13 diff
(98.5 %id)
BF342156 brain, glioblastoma with EGFR amplification .b 89 to 790 13 to 709       697/709
(98 %)
11 diff
(98.5 %id)
TI_57147792   .b 89 to 1012 77 to 1010 V6A V45S A46R L47W V48C ...     934/1034
(90 %)
30 diff
(97.1 %id)
TI_57152092   .b 89 to 769 31 to 715       685/803
(85 %)
18 diff
(97.8 %id)
CN291940 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 90 to 565 3 to 478       476/478
(99 %)
6 diff
(98.8 %id)
CF141311 CNCAP(3)T-225 cell line, Prostate .b 90 to 555 8 to 474       467/474
(98 %)
10 diff
(97.9 %id)
BG473064 eye, retinoblastoma .b 90 to 686 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
BG741960 skin .b 90 to 777 1 to 695       695/961
(72 %)
22 diff
(97.8 %id)
BI489584 pooled brain, lung, testis .b 90 to 939 1 to 848 V6A L7W V8W A9P S10R ...     848/853
(99 %)
17 diff
(98.1 %id)
BI822629 pooled brain, lung, testis .b 90 to 688 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
DR761515 embryonic stem .b 90 to 921 1 to 832 exact     832/832
(100 %)
1 diff
(99.9 %id)
TI_43961237   .b 90 to 939 61 to 908 V6A L7W V8W A9P S10R ...     848/913
(92 %)
20 diff
(97.9 %id)
TI_57202006   .b 90 to 918 21 to 854 V6A S16V A17C F18I T19H ...     834/854
(97 %)
22 diff
(97.5 %id)
CR609783 Placenta Cot 25-normalized .b 91 to 1657 1 to 1567 exact     1567/1567
(100 %)
0 diff
(100 %id)
AL539738 brain, fetal brain .b 91 to 911 1 to 819 V6A A33P L34F H35T L36S ... fully sequenced,   819/819
(100 %)
3 diff
(99.7 %id)
BX359334 Placenta Cot 25-normalized .b 91 to 1091 1 to 989 V6A A33X L34F H35T L36S ...     989/989
(100 %)
16 diff
(98.4 %id)
BQ440725 melanotic melanoma, skin .b 91 to 778 1 to 692       692/853
(81 %)
9 diff
(99.0 %id)
BM927466 lymph, lymphoma, cell line .b 92 to 1057 1 to 971 I213X K214Q G217X E224G V225S ...     971/1080
(89 %)
28 diff
(97.5 %id)
BQ055714 lymph, lymphoma, cell line .b 92 to 959 1 to 876 Q232P K233E M243L A247G I251L ...     876/1073
(81 %)
27 diff
(97.5 %id)
BQ059489 lymph, lymphoma, cell line .b 92 to 1098 1 to 1026 G217X E224G R260E     1026/1027
(99 %)
37 diff
(96.4 %id)
BQ065585 lymph, lymphoma, cell line .b 92 to 1015 1 to 942 A215G L216P A218C K219Q H220A ...     942/944
(99 %)
26 diff
(97.3 %id)
BQ679395 melanotic melanoma, cell line, skin .b 92 to 973 1 to 885 V6A R188X E197Q P205S L216P ...     885/889
(99 %)
15 diff
(98.4 %id)
CV026030 mixed .b 94 to 556 1 to 463       463/463
(100 %)
15 diff
(96.8 %id)
BI822831 pooled brain, lung, testis .b 94 to 980 1 to 891 V6A V45S A46R L47W V48C ...     891/892
(99 %)
19 diff
(97.9 %id)
TI_57201964   .b 94 to 980 66 to 956 V6A V45S A46R L47W V48C ...     891/957
(93 %)
23 diff
(97.6 %id)
TI_1948102241   .b 94 to 552 130 to 588   fully sequenced,   459/588
(78 %)
6 diff
(99.0 %id)
TI_1948102408   .b 94 to 552 134 to 592   fully sequenced,   459/592
(77 %)
6 diff
(99.0 %id)
TI_1948102580   .b 94 to 901 127 to 937 A2T V6A A210P A215P V236W ... fully sequenced,   811/937
(86 %)
24 diff
(97.5 %id)
TI_1948102739   .b 94 to 552 128 to 586   fully sequenced,   459/586
(78 %)
6 diff
(99.0 %id)
CN291942 embryonic stem cells, cell lines H1, H7, andH9 .b 95 to 442 1 to 349       349/349
(100 %)
2 diff
(99.5 %id)
CN291945 embryonic stem cells, cell lines H1, H7, andH9 .b 95 to 653 1 to 559       559/559
(100 %)
4 diff
(99.3 %id)
BI818453 pooled brain, lung, testis .b 96 to 849 1 to 755       755/756
(99 %)
7 diff
(99.1 %id)
BI822758 pooled brain, lung, testis .b 96 to 918 1 to 828       828/828
(100 %)
18 diff
(97.9 %id)
BI760634 pooled colon, kidney, stomach .b 96 to 1012 1 to 927       927/951
(97 %)
26 diff
(97.3 %id)
BI763587 pooled colon, kidney, stomach .b 96 to 853 1 to 766       766/766
(100 %)
23 diff
(97.0 %id)
BQ072746 leukocyte .b 96 to 964 16 to 897       882/1088
(81 %)
20 diff
(98.2 %id)
BI915468 brain .b 97 to 990 1 to 898       898/899
(99 %)
30 diff
(96.7 %id)
BM927017 brain .b 97 to 781 1 to 683       683/1020
(66 %)
12 diff
(98.9 %id)
TI_57239355   .b 97 to 990 87 to 984       898/985
(91 %)
34 diff
(96.6 %id)
BX397291 Placenta Cot 25-normalized .b 98 to 894 1 to 796   fully sequenced,   796/796
(100 %)
2 diff
(99.8 %id)
BE275721 melanotic melanoma, skin .b 98 to 661 1 to 564       564/564
(100 %)
3 diff
(99.5 %id)
BE729677 melanotic melanoma, skin .b 98 to 778 1 to 676       676/947
(71 %)
17 diff
(98.3 %id)
BE727087 melanotic melanoma, skin .b 98 to 882 1 to 782       782/782
(100 %)
14 diff
(98.3 %id)
BI758445 brain .b 98 to 824 15 to 739       725/739
(98 %)
6 diff
(99.2 %id)
BI835330 pooled pancreas and spleen .b 98 to 849 1 to 753       753/754
(99 %)
6 diff
(99.3 %id)
CD109057 brain, Pituitary .b 98 to 932 1 to 839       839/846
(99 %)
7 diff
(99.2 %id)
TI_57215361   .b 98 to 824 15 to 739       725/739
(98 %)
6 diff
(99.2 %id)
TI_57164736   .b 98 to 849 29 to 781       753/782
(96 %)
11 diff
(98.6 %id)
CN291943 embryonic stem cells, DMSO-treated H9 cellline .b 107 to 652 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
CX762754 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 108 to 862 1 to 754     Submitted on the opposite strand 754/754
(100 %)
2 diff
(99.8 %id)
CR595541 adult brain .b 111 to 1660 1 to 1550   tiling clone,   1550/1550
(100 %)
0 diff
(100 %id)
BX463319 adult brain, brain .b 111 to 1133 1 to 1012       1012/1012
(100 %)
15 diff
(98.6 %id)
BU859123 ovary, teratocarcinoma, cell line .b 117 to 1012 1 to 899       899/916
(98 %)
9 diff
(99.1 %id)
BU145757 dorsal root ganglia .b 118 to 977 1 to 866       866/944
(91 %)
13 diff
(98.7 %id)
BE379238 endometrium, adenocarcinoma cell line, uterus .b 127 to 772 1 to 652       652/722
(90 %)
18 diff
(97.6 %id)
BM543489 brain, hippocampus .b 127 to 781 41 to 695       655/1063
(61 %)
17 diff
(98.5 %id)
BE396237 endometrium, adenocarcinoma cell line, uterus .b 184 to 812 36 to 671       636/672
(94 %)
18 diff
(97.4 %id)
BQ669009 epidermoid carcinoma, cell line, salivary gland .b 211 to 871 1 to 662       662/880
(75 %)
8 diff
(99.1 %id)
BQ675158 epidermoid carcinoma, cell line, salivary gland .b 211 to 1042 1 to 857       810/952
(85 %)
31 diff
(96.8 %id)
BE884411 leiomyosarcoma, uterus .b 232 to 856 1 to 624       624/625
(99 %)
6 diff
(99.1 %id)
BQ636016 eye, retina .b 268 to 906 1 to 639       639/639
(100 %)
0 diff
(100 %id)
T75374 whole brain .b 288 to 620 7 to 344       338/362
(93 %)
18 diff
(95.1 %id)
BI261201 cervical carcinoma cell line, cervix .b 302 to 895 17 to 610       594/610
(97 %)
8 diff
(98.7 %id)
BQ644351 hepatocellular carcinoma, cell line, Liver .b 305 to 1073 1 to 776       776/1031
(75 %)
52 diff
(95.0 %id)
BQ649231 hepatocellular carcinoma, cell line, Liver .b 309 to 1208 1 to 921       921/992
(92 %)
31 diff
(96.9 %id)
AA369070 placenta .b 334 to 633 1 to 300       300/300
(100 %)
0 diff
(100 %id)
AA374282 lung .b 355 to 627 1 to 272       272/272
(100 %)
1 diff
(99.7 %id)
AW957487   .b 356 to 889 1 to 532       532/533
(99 %)
5 diff
(99.1 %id)
BG259626 embryonal carcinoma, cell line, testis .b 359 to 1056 1 to 702       702/1099
(63 %)
14 diff
(98.8 %id)
BE744570 adenocarcinoma cell line, ovary .b 361 to 1074 1 to 713       713/721
(98 %)
11 diff
(98.5 %id)
BX110774 liver and spleen .b 366 to 1039 1 to 673       673/673
(100 %)
3 diff
(99.6 %id)
R91742 liver and spleen .b 366 to 770 1 to 409       409/421
(97 %)
18 diff
(95.8 %id)
CD516075 White Matter .b 387 to 1203 1 to 829       829/904
(91 %)
16 diff
(98.3 %id)
AW579582 head_neck .b 398 to 905 541 to 36       506/559
(90 %)
2 diff
(99.7 %id)
CN291934 embryonic stem cells, cell lines H1, H7, andH9 .b 399 to 903 1 to 504       504/504
(100 %)
3 diff
(99.5 %id)
BM465929 eye, retinoblastoma .b 450 to 1222 1 to 780       780/895
(87 %)
12 diff
(98.7 %id)
BQ424732 melanotic melanoma, skin .b 463 to 1333 1 to 881       881/886
(99 %)
24 diff
(97.3 %id)
AW991535 breast_normal .b 467 to 1069 10 to 612       603/612
(98 %)
12 diff
(98.1 %id)
BE813186 breast_normal .b 467 to 1097 630 to 2       629/641
(98 %)
0 diff
(100 %id)
BM782396 stomach .b 467 to 1042 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
AW372627 breast .b 469 to 1088 1 to 615       615/615
(100 %)
24 diff
(96.1 %id)
AW579551 head_neck .b 474 to 901 444 to 12       431/444
(97 %)
14 diff
(96.9 %id)
AW372632 breast .b 475 to 1088 11 to 618       608/618
(98 %)
12 diff
(98.1 %id)
CN291936 embryonic stem cells, DMSO-treated H9 cellline .b 482 to 1177 1 to 696       696/696
(100 %)
5 diff
(99.3 %id)
BM854449 Ascites, stomach .b 482 to 976 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
TI_1948102242   .b 491 to 899 519 to 111   fully sequenced,   409/519
(78 %)
0 diff
(100 %id)
TI_1948102409   .b 491 to 899 533 to 125   fully sequenced,   409/533
(76 %)
0 diff
(100 %id)
TI_1948102581   .b 491 to 899 527 to 120   fully sequenced,   408/527
(77 %)
0 diff
(100 %id)
TI_1948102740   .b 491 to 899 531 to 124   fully sequenced,   408/531
(76 %)
0 diff
(100 %id)
CB216279 normal endometrium, mid-secretory phase,cycle day 23, uterus .b 506 to 1042 1 to 538       538/538
(100 %)
2 diff
(99.7 %id)
BG490421 large cell carcinoma, lung .b 511 to 1229 1 to 717       717/717
(100 %)
12 diff
(98.4 %id)
FN130942 breast carcinoma .b 522 to 625 2 to 105       104/105
(99 %)
5 diff
(95.3 %id)
BU539755 adenocarcinoma, cell line, breast .b 535 to 1425 1 to 898       896/900
(99 %)
14 diff
(98.5 %id)
BI261207 cervical carcinoma cell line, cervix .b 556 to 1398 19 to 863       721/871
(82 %)
25 diff
(97.2 %id)
BI912712 brain .b 556 to 1301 1 to 754       754/891
(84 %)
36 diff
(96.0 %id)
TI_57238380   .b 556 to 1301 34 to 787       752/924
(81 %)
41 diff
(95.6 %id)
BE547927 cervical carcinoma cell line, cervix .b 558 to 1233 1 to 667       667/809
(82 %)
21 diff
(97.5 %id)
BQ688071 ductal carcinoma, cell line, Pancreas .b 563 to 1425 1 to 880       880/915
(96 %)
29 diff
(96.9 %id)
BG577308 breast, mammary adenocarcinoma, cell line .b 573 to 1435 1 to 864       864/864
(100 %)
55 diff
(93.7 %id)
BX457895 neuroblastoma .b 784 to 1633 848 to 1       848/851
(99 %)
22 diff
(97.5 %id)
AL571172 placenta, Placenta Cot 25-normalized .b 792 to 1631 844 to 1       844/844
(100 %)
8 diff
(99.1 %id)
BX401042   .b 818 to 1630 817 to 1       817/817
(100 %)
18 diff
(97.8 %id)
AL518348 brain, neuroblastoma, neuroblastoma cells .b 825 to 1629 806 to 1   fully sequenced,   806/806
(100 %)
20 diff
(97.6 %id)
AL515359 neuroblastoma, placenta .b 840 to 1662 824 to 1   fully sequenced,   824/824
(100 %)
19 diff
(97.7 %id)
BX357483 Placenta Cot 25-normalized .b 842 to 1607 794 to 28   fully sequenced,   767/794
(96 %)
16 diff
(98.0 %id)
BX350897 Neuroblastoma Cot 25-normalized .b 845 to 1655 811 to 1   fully sequenced,   811/811
(100 %)
14 diff
(98.3 %id)
AL516823 brain, neuroblastoma, neuroblastoma cells .b 848 to 1608 773 to 11   fully sequenced,   763/773
(98 %)
25 diff
(96.8 %id)
AL567969 brain, fetal brain .b 851 to 1631 792 to 1   fully sequenced,   792/792
(100 %)
63 diff
(92.1 %id)
BX397290 Placenta Cot 25-normalized .b 864 to 1595 731 to 1   fully sequenced,   731/731
(100 %)
7 diff
(99.1 %id)
AL539737 brain, fetal brain .b 881 to 1469 656 to 68   fully sequenced,   589/656
(89 %)
16 diff
(97.6 %id)
BX444062 fetal liver, Liver .b 899 to 1639 744 to 8   fully sequenced,   737/744
(99 %)
10 diff
(98.7 %id)
AL580481 T cells from T cell leukemia .b 917 to 1607 692 to 1   fully sequenced,   692/692
(100 %)
23 diff
(96.7 %id)
AL574303 placenta, Placenta Cot 25-normalized .b 919 to 1598 685 to 1   fully sequenced,   685/685
(100 %)
10 diff
(98.6 %id)
AL517915 brain, neuroblastoma, neuroblastoma cells .b 920 to 1535 721 to 108   fully sequenced,   614/721
(85 %)
19 diff
(97.4 %id)
AL515752 brain, neuroblastoma, neuroblastoma cells .b 975 to 1639 665 to 1   fully sequenced,   665/665
(100 %)
9 diff
(98.7 %id)
BX359360 Placenta Cot 25-normalized .b 1080 to 1633 569 to 1   fully sequenced,   634/634
(100 %)
12 diff
(98.2 %id)
BX411729 neuroblastoma .b 1114 to 1620 519 to 14       506/820
(61 %)
0 diff
(100 %id)
AW246022 lung, small cell carcinoma .b 1219 to 1659 454 to 14       441/454
(97 %)
0 diff
(100 %id)
R92169 liver and spleen .b 1256 to 1606 355 to 1       355/355
(100 %)
7 diff
(98.1 %id)
BM042188 melanotic melanoma, cell line, skin .c 1 to 710 1 to 712       712/712
(100 %)
11 diff
(98.5 %id)
BU189334 melanotic melanoma, cell line, skin .c 2 to 943 35 to 997   tiling clone,   963/1011
(95 %)
45 diff
(95.6 %id)
BU158103 melanotic melanoma, cell line, skin .c 2 to 649 21 to 673       653/975
(66 %)
26 diff
(97.4 %id)
BU185739 melanotic melanoma, cell line, skin .c 2 to 772 32 to 817       786/984
(79 %)
33 diff
(96.7 %id)
BU190316 melanotic melanoma, cell line, skin .c 3 to 865 1 to 872   tiling clone,   872/873
(99 %)
11 diff
(98.8 %id)
BQ679801 melanotic melanoma, cell line, skin .c 3 to 741 1 to 746       746/958
(77 %)
25 diff
(97.4 %id)
BQ677053 melanotic melanoma, cell line, skin .c 3 to 903 1 to 910   tiling clone,   910/911
(99 %)
16 diff
(98.3 %id)
BQ679370 melanotic melanoma, cell line, skin .c 3 to 908 1 to 910   tiling clone,   910/929
(97 %)
16 diff
(98.3 %id)
AA252000 germinal center B cell .d 1 to 365 1 to 354   tiling clone,   358/354
(101 %)
22 diff
(93.8 %id)
BQ643638 hepatocellular carcinoma, cell line, Liver .d 113 to 780 1 to 673       673/922
(72 %)
11 diff
(98.9 %id)
BQ647697 hepatocellular carcinoma, cell line, Liver .d 113 to 798 1 to 687   tiling clone, AAA   687/687
(100 %)
3 diff
(99.6 %id)
AW967680   .d 165 to 802 640 to 3   tiling clone, Submitted on the opposite strand 638/663
(96 %)
10 diff
(98.5 %id)
AA251772 germinal center B cell .d 455 to 729 275 to 1       275/275
(100 %)
2 diff
(99.3 %id)
NM_198155.3   .e 1 to 1575 1 to 1575 V6A RefSeq,   1575/1575
(100 %)
2 diff
(99.9 %id)
BG828456 muscle, rhabdomyosarcoma .e 4 to 380 1 to 379   tiling clone,   379/513
(73 %)
8 diff
(98.5 %id)
TI_154171757   .e 6 to 395 80 to 469       390/969
(40 %)
6 diff
(99.4 %id)
CX788692 human embryonic stem cells .e 9 to 808 1 to 800 exact tiling clone,   800/800
(100 %)
0 diff
(100 %id)
BI260123 cervical carcinoma cell line, cervix .e 12 to 433 1 to 433       426/435
(97 %)
29 diff
(93.4 %id)
T68039 Liver .e 19 to 354 1 to 332       332/332
(100 %)
21 diff
(93.7 %id)
BG489022 large cell carcinoma, lung .e 64 to 830 1 to 784 V6A L12S A13R A14C A15G ...     784/859
(91 %)
39 diff
(95.5 %id)
D86062 brain .e 69 to 966 1 to 898 V6A     898/898
(100 %)
1 diff
(99.9 %id)
DN990657 brain, whole brain .e 87 to 687 17 to 618       602/618
(97 %)
10 diff
(98.4 %id)
BG766139 melanotic melanoma, high MDR (cell line), skin .e 95 to 678 1 to 693       608/980
(62 %)
38 diff
(96.2 %id)
F05196 brain, total brain .e 96 to 320 1 to 224       224/224
(100 %)
5 diff
(97.8 %id)
CN291932 embryonic stem cells, DMSO-treated H9 cellline .e 100 to 380 1 to 281       281/281
(100 %)
4 diff
(98.6 %id)
BE787242 large cell carcinoma, lung .e 110 to 768 1 to 651       651/900
(72 %)
11 diff
(98.8 %id)
BG034412 breast, mammary adenocarcinoma, cell line .e 189 to 964 1 to 765       765/968
(79 %)
18 diff
(98.2 %id)
AW991387 breast_normal .e 453 to 988 1 to 535       535/535
(100 %)
24 diff
(95.6 %id)
BQ051904 blood, natural killer cells, cell line .e 466 to 1463 26 to 1034       1009/1037
(97 %)
30 diff
(97.2 %id)
BX386639   .e 515 to 1498 986 to 12       975/986
(98 %)
11 diff
(98.9 %id)
AA884725 pooled .e 537 to 795 259 to 1       259/259
(100 %)
5 diff
(98.1 %id)
CF457188 peripheral nervous system .e 537 to 1308 31 to 801       771/810
(95 %)
17 diff
(98.0 %id)
AA343742 gall bladder .e 560 to 816 1 to 258       258/258
(100 %)
7 diff
(97.3 %id)
BI824121 pooled brain, lung, testis .e 578 to 1268 1 to 688       688/688
(100 %)
11 diff
(98.5 %id)
TI_57201305   .e 579 to 1268 56 to 742       687/742
(92 %)
15 diff
(98.0 %id)
BI051288 placenta_normal .e 593 to 1022 427 to 1       427/427
(100 %)
10 diff
(97.7 %id)
BF973338 leiomyosarcoma cell line, uterus .e 596 to 1147 1 to 552       552/1204
(45 %)
20 diff
(98.4 %id)
BE393624 endometrium, adenocarcinoma cell line, uterus .e 603 to 1188 1 to 591       591/591
(100 %)
27 diff
(95.5 %id)
BE394450 endometrium, adenocarcinoma cell line, uterus .e 603 to 1192 1 to 593       593/598
(99 %)
26 diff
(95.7 %id)
AA045710 uterus .e 621 to 1064 1 to 450       450/452
(99 %)
9 diff
(98.1 %id)
BE706105 head_neck .e 671 to 805 163 to 27       137/171
(80 %)
0 diff
(100 %id)
BX351906 Placenta Cot 25-normalized .e 673 to 1557 884 to 1       884/887
(99 %)
45 diff
(95.0 %id)
BX414430 adult brain, brain .e 677 to 1560 887 to 1       887/892
(99 %)
23 diff
(97.5 %id)
BQ648329 hepatocellular carcinoma, cell line, Liver .e 681 to 1561 929 to 36   tiling clone, AAA Submitted on the opposite strand 894/923
(96 %)
26 diff
(97.2 %id)
BX435086 brain, fetal brain .e 683 to 1557 873 to 1   tiling clone, Submitted on the opposite strand 873/876
(99 %)
9 diff
(99.0 %id)
BX351580 Placenta Cot 25-normalized .e 699 to 1560 868 to 1       868/901
(96 %)
26 diff
(97.2 %id)
T59991 ovary .e 722 to 1125 1 to 415       415/415
(100 %)
6 diff
(98.6 %id)
BX393330   .e 737 to 1551 811 to 1       811/884
(91 %)
22 diff
(97.6 %id)
BQ648094 hepatocellular carcinoma, cell line, Liver .e 741 to 1561 863 to 36   AAA Submitted on the opposite strand 828/902
(91 %)
37 diff
(95.9 %id)
BI050434 placenta_normal .e 745 to 1035 282 to 2       281/282
(99 %)
0 diff
(100 %id)
BQ648569 hepatocellular carcinoma, cell line, Liver .e 745 to 1561 858 to 36   AAA Submitted on the opposite strand 823/924
(89 %)
13 diff
(98.6 %id)
BQ652689 hepatocellular carcinoma, cell line, Liver .e 746 to 1561 882 to 56   AAA Submitted on the opposite strand 827/837
(98 %)
24 diff
(97.2 %id)
BI003196 head_normal .e 760 to 1063 319 to 19       301/321
(93 %)
0 diff
(100 %id)
TI_149287588   .e 760 to 1559 889 to 97   AAA   793/1130
(70 %)
26 diff
(97.7 %id)
CB853278 Human Lung Epithelial cells, lung .e 763 to 1562 817 to 25       793/822
(96 %)
0 diff
(100 %id)
AA447401   .e 766 to 1284 8 to 524   fully sequenced,   517/524
(98 %)
8 diff
(98.5 %id)
BX452511 adult brain, brain .e 767 to 1562 1 to 796       796/796
(100 %)
5 diff
(99.4 %id)
BM923765 pooled colon, kidney, stomach .e 767 to 1562 15 to 812       798/992
(80 %)
10 diff
(99.0 %id)
BM714315 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 770 to 1257 1 to 488   fully sequenced,   488/488
(100 %)
0 diff
(100 %id)
BG950629 colon .e 774 to 1063 301 to 7       295/303
(97 %)
0 diff
(100 %id)
BQ670650 epidermoid carcinoma, cell line, salivary gland .e 777 to 1536 1 to 768       768/973
(78 %)
40 diff
(95.9 %id)
BQ669263 epidermoid carcinoma, cell line, salivary gland .e 777 to 1560 1 to 781   AAA   781/781
(100 %)
24 diff
(97.0 %id)
TI_227712898   .e 813 to 1559 865 to 134   AAA   732/875
(83 %)
37 diff
(95.8 %id)
ES312735 beard hair, skin .e 827 to 978 1 to 152       152/152
(100 %)
0 diff
(100 %id)
TI_227713537   .e 836 to 1559 854 to 136   AAA   719/958
(75 %)
52 diff
(94.6 %id)
BG014442 placenta_normal .e 847 to 1037 195 to 6       190/195
(97 %)
0 diff
(100 %id)
BU621707 cell lines, Chondrosarcoma .e 851 to 1559 726 to 19   AAA   708/708
(100 %)
2 diff
(99.8 %id)
BG999373 head_normal .e 853 to 1051 200 to 1       200/200
(100 %)
7 diff
(96.5 %id)
CA430487 Cell Line, Chondrosarcoma .e 854 to 1559 724 to 19   AAA   706/706
(100 %)
4 diff
(99.5 %id)
BX359333 Placenta Cot 25-normalized .e 866 to 1530 678 to 1       678/985
(68 %)
23 diff
(97.7 %id)
BE549338 cervical carcinoma cell line, cervix .e 872 to 1556 1 to 689       689/944
(72 %)
44 diff
(95.4 %id)
TI_149301111   .e 885 to 1559 775 to 100   AAA   676/676
(100 %)
2 diff
(99.8 %id)
W68269 heart .e 896 to 1220 1 to 332   fully sequenced,   332/332
(100 %)
9 diff
(97.3 %id)
TI_149279284   .e 897 to 1561 772 to 108   AAA   665/672
(98 %)
3 diff
(99.6 %id)
BU690098 Human Lung Epithelial cells, lung .e 897 to 1561 681 to 17   AAA   665/666
(99 %)
5 diff
(99.3 %id)
BQ438133 leiomyosarcoma, uterus .e 901 to 1559 715 to 57   AAA Submitted on the opposite strand 659/665
(99 %)
0 diff
(100 %id)
TI_149278145   .e 901 to 1562 781 to 116       666/786
(84 %)
0 diff
(100 %id)
TI_159699429   .e 901 to 1559 794 to 139   AAA   656/907
(72 %)
32 diff
(96.5 %id)
BM979626 lung, Primary Lung Epithelial Cells .e 901 to 1511 1 to 613     Submitted on the opposite strand 613/613
(100 %)
4 diff
(99.4 %id)
CA314769 Human Lung Epithelial cells, lung .e 901 to 1567 685 to 19   AAA   667/705
(94 %)
3 diff
(99.6 %id)
BU616052 Bone, Subchondral Bone .e 901 to 1561 679 to 19   AAA   661/712
(92 %)
1 diff
(99.9 %id)
BU622456 cell lines, Chondrosarcoma .e 904 to 1561 673 to 17   AAA   657/657
(100 %)
2 diff
(99.7 %id)
BM977055 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 905 to 1559 673 to 19   AAA   655/655
(100 %)
1 diff
(99.9 %id)
AV699450 hepatocellular carcinoma .e 908 to 1565 1 to 661   AAA Submitted on the opposite strand 661/663
(99 %)
48 diff
(92.8 %id)
BM969479 lung, Primary Lung Epithelial Cells .e 911 to 1561 667 to 17   AAA   651/651
(100 %)
1 diff
(99.9 %id)
BU678180 lung .e 913 to 1561 667 to 19   AAA   649/649
(100 %)
4 diff
(99.4 %id)
AW967464   .e 914 to 1546 1 to 632       632/634
(99 %)
22 diff
(96.6 %id)
FN067208 breast carcinoma .e 917 to 984 68 to 1     Submitted on the opposite strand 68/68
(100 %)
0 diff
(100 %id)
FN147642 breast carcinoma .e 918 to 1004 90 to 1     Submitted on the opposite strand 90/92
(97 %)
3 diff
(96.8 %id)
AA421857 ovarian tumor, ovary .e 927 to 1024 1 to 98       98/98
(100 %)
3 diff
(97.0 %id)
BI088550 cervix .e 927 to 1552 631 to 1     Submitted on the opposite strand 631/672
(93 %)
28 diff
(95.9 %id)
BM990543 lung, Metastatic Chondrosarcoma .e 927 to 1559 651 to 19   AAA   633/633
(100 %)
1 diff
(99.9 %id)
CA419891 Bone, Human Chondrosarcoma Cell Line .e 927 to 1559 649 to 17   AAA   633/633
(100 %)
3 diff
(99.6 %id)
BU618777 Cell Line, Chondrosarcoma .e 927 to 1559 651 to 19   AAA   633/633
(100 %)
3 diff
(99.6 %id)
BQ447748 Knee, Osteoarthritic Cartilage .e 931 to 1559 644 to 19   AAA   626/629
(99 %)
5 diff
(99.3 %id)
TI_149288551   .e 939 to 1559 742 to 125   AAA   618/667
(92 %)
22 diff
(96.8 %id)
BE562968 endometrium, adenocarcinoma cell line, uterus .e 942 to 1555 1 to 611       611/612
(99 %)
7 diff
(98.9 %id)
BQ005475 Chondrosarcoma, Left Pelvis .e 955 to 1565 629 to 19   AAA   611/611
(100 %)
3 diff
(99.6 %id)
AA159087 Pancreas .e 962 to 1294 1 to 351   fully sequenced,   351/351
(100 %)
22 diff
(93.8 %id)
AA167472   .e 962 to 1512 1 to 548     Submitted on the opposite strand 548/559
(98 %)
17 diff
(97.0 %id)
TI_149307496   .e 965 to 1559 688 to 94   AAA   595/961
(61 %)
1 diff
(99.9 %id)
BM979268 lung, Primary Lung Epithelial Cells .e 965 to 1559 613 to 19   AAA   595/603
(98 %)
1 diff
(99.9 %id)
BU608298 Human Lung Epithelial cells, lung .e 965 to 1561 615 to 19   AAA   597/597
(100 %)
2 diff
(99.7 %id)
CB243917 Human Lung Epithelial cells, lung .e 965 to 1561 613 to 17   AAA   597/597
(100 %)
1 diff
(99.9 %id)
BI007654 kidney_tumor .e 966 to 1484 518 to 1       518/518
(100 %)
12 diff
(97.7 %id)
BI009807 kidney_tumor .e 966 to 1491 537 to 14       524/537
(97 %)
0 diff
(100 %id)
BG282938 adenocarcinoma, cell line, Prostate .e 970 to 1563 1 to 593       593/623
(95 %)
4 diff
(99.4 %id)
BE936875 ovary .e 999 to 1534 536 to 2       535/541
(98 %)
0 diff
(100 %id)
W07866 lung .e 1010 to 1312 1 to 310   fully sequenced,   310/310
(100 %)
3 diff
(99.1 %id)
CD367276 Alveolar Macrophage, lung .e 1010 to 1559 568 to 19   AAA   550/550
(100 %)
13 diff
(97.7 %id)
AV713935   .e 1011 to 1559 1 to 549   AAA   549/549
(100 %)
0 diff
(100 %id)
BE379131 endometrium, adenocarcinoma cell line, uterus .e 1014 to 1557 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
CA421541 Bone, Enchondroma cell line .e 1015 to 1559 563 to 19   AAA   545/545
(100 %)
8 diff
(98.6 %id)
BM993649 lung, Metastatic Chondrosarcoma .e 1019 to 1559 559 to 19   AAA   541/541
(100 %)
2 diff
(99.7 %id)
CD522626 pooled .e 1019 to 1560 1 to 542       542/550
(98 %)
2 diff
(99.7 %id)
CN291931 embryonic stem cells, cell lines H1, H7, andH9 .e 1020 to 1559 12 to 549   AAA   538/549
(97 %)
6 diff
(99.0 %id)
AI826593 normal prostate, Prostate .e 1025 to 1560 544 to 9       536/544
(98 %)
0 diff
(100 %id)
AI149538 placenta .e 1026 to 1560 535 to 1       535/535
(100 %)
3 diff
(99.5 %id)
AI802921 pooled .e 1034 to 1565 532 to 1       532/532
(100 %)
1 diff
(99.9 %id)
TI_154171719   .e 1039 to 1559 676 to 152   AAA Submitted on the opposite strand 525/884
(59 %)
0 diff
(100 %id)
BM972884 lung .e 1039 to 1559 539 to 19   AAA   521/521
(100 %)
2 diff
(99.7 %id)
AW166106 brain, medulloblastoma .e 1040 to 1562 526 to 4       523/526
(99 %)
0 diff
(100 %id)
BQ183228 Knee, Osteoarthritic Cartilage .e 1051 to 1559 527 to 19   AAA   509/509
(100 %)
2 diff
(99.7 %id)
AV649568 corresponding non cancerous liver tissue .e 1052 to 1561 1 to 510   AAA Submitted on the opposite strand 510/510
(100 %)
1 diff
(99.9 %id)
DN918404   .e 1061 to 1559 515 to 17   AAA   499/499
(100 %)
4 diff
(99.2 %id)
W58003 heart .e 1065 to 1511 1 to 448       448/448
(100 %)
2 diff
(99.6 %id)
AI470123 pooled .e 1073 to 1560 495 to 8       488/495
(98 %)
0 diff
(100 %id)
BE045820 follicular carcinoma, thyroid .e 1076 to 1562 487 to 1       487/487
(100 %)
1 diff
(99.8 %id)
N30049 placenta .e 1081 to 1574 508 to 2       507/508
(99 %)
0 diff
(100 %id)
AW008067 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1082 to 1560 486 to 8       479/486
(98 %)
0 diff
(100 %id)
AI469831 pooled .e 1083 to 1562 486 to 7       480/486
(98 %)
0 diff
(100 %id)
AI123124 heart .e 1084 to 1562 485 to 7       479/485
(98 %)
0 diff
(100 %id)
H69117 liver and spleen .e 1086 to 1560 481 to 1     Submitted on the opposite strand 481/482
(99 %)
11 diff
(97.8 %id)
AA034250.
matches multiple genes
heart .e 1099 to 1561 1 to 461     also hits gene PPT1 461/489
(94 %)
3 diff
(99.4 %id)
AI564789 anaplastic oligodendroglioma, brain .e 1099 to 1560 463 to 2       462/463
(99 %)
0 diff
(100 %id)
CB958694 Pooled-Glandular .e 1105 to 1561 1 to 457       457/463
(98 %)
4 diff
(99.2 %id)
BE890656 melanotic melanoma, skin .e 1106 to 1557 1 to 457       457/460
(99 %)
9 diff
(98.1 %id)
AI077694 brain, glioblastoma (pooled) .e 1109 to 1561 464 to 12   AAA   453/453
(100 %)
0 diff
(100 %id)
AW005746 anaplastic oligodendroglioma, brain .e 1111 to 1559 460 to 12   AAA   449/449
(100 %)
4 diff
(99.2 %id)
AI937795 anaplastic oligodendroglioma, brain .e 1112 to 1560 451 to 2       450/451
(99 %)
0 diff
(100 %id)
DB545931 hippocampus .e 1114 to 1559 1 to 447     Submitted on the opposite strand 447/447
(100 %)
3 diff
(99.4 %id)
BE674829 B-cell, chronic lymphotic leukemia .e 1115 to 1560 454 to 9       446/454
(98 %)
0 diff
(100 %id)
BM696031 eye, human retina .e 1117 to 1534 1 to 417       417/417
(100 %)
2 diff
(99.6 %id)
AA811370 germinal center B cell .e 1118 to 1561 465 to 22   AAA   444/444
(100 %)
1 diff
(99.8 %id)
CB161223 Liver .e 1118 to 1559 481 to 41   AAA Submitted on the opposite strand 441/441
(100 %)
3 diff
(99.4 %id)
BM855564 stomach .e 1121 to 1562 1 to 442       442/449
(98 %)
3 diff
(99.4 %id)
BM855767 stomach .e 1121 to 1366 1 to 246       246/246
(100 %)
1 diff
(99.6 %id)
AA772592 parathyroid gland, parathyroid tumor .e 1124 to 1560 445 to 9       437/445
(98 %)
0 diff
(100 %id)
BF087676 head_neck .e 1125 to 1509 10 to 394       385/394
(97 %)
6 diff
(98.5 %id)
CB132347 Liver .e 1126 to 1559 485 to 52   AAA Submitted on the opposite strand 434/434
(100 %)
7 diff
(98.4 %id)
CN291938 embryonic stem cells, cell lines H1, H7, andH9 .e 1127 to 1559 443 to 11   AAA Submitted on the opposite strand 433/433
(100 %)
6 diff
(98.7 %id)
AA167471   .e 1132 to 1556 426 to 1     Submitted on the opposite strand 426/426
(100 %)
2 diff
(99.6 %id)
T67889 Liver .e 1141 to 1541 410 to 1       410/419
(97 %)
12 diff
(97.2 %id)
AA045757 uterus .e 1144 to 1574 442 to 3   tiling clone,   440/442
(99 %)
0 diff
(100 %id)
AI268488 carcinoid, lung .e 1148 to 1558 411 to 1       411/415
(99 %)
4 diff
(99.1 %id)
AA777080 heart .e 1150 to 1559 427 to 18   AAA   410/410
(100 %)
1 diff
(99.8 %id)
AA095472   .e 1151 to 1493 23 to 363       341/366
(93 %)
9 diff
(97.6 %id)
BG575699 breast, mammary adenocarcinoma, cell line .e 1152 to 1559 1 to 408   AAA   408/408
(100 %)
1 diff
(99.8 %id)
FN089625 breast carcinoma .e 1153 to 1261 105 to 1     Submitted on the opposite strand 105/106
(99 %)
3 diff
(97.2 %id)
CA427980 Bone, Subchondral Bone .e 1153 to 1559 425 to 19   AAA   407/413
(98 %)
3 diff
(99.3 %id)
CA748865 Bone, Subchondral Bone .e 1153 to 1559 425 to 19   AAA   407/413
(98 %)
1 diff
(99.8 %id)
AI285112 adenocarcinoma, colon .e 1158 to 1561 404 to 1       404/404
(100 %)
1 diff
(99.8 %id)
T59900 ovary .e 1159 to 1556 408 to 1       408/408
(100 %)
13 diff
(96.9 %id)
AI355963 brain, glioblastoma (pooled) .e 1159 to 1561 423 to 21   AAA   403/403
(100 %)
9 diff
(97.8 %id)
AI147190 heart .e 1173 to 1542 401 to 29       373/401
(93 %)
0 diff
(100 %id)
BM923176 pooled colon, kidney, stomach .e 1173 to 1559 10 to 396   AAA   387/396
(97 %)
6 diff
(98.5 %id)
BI060726 uterus_tumor .e 1183 to 1417 1 to 235       235/235
(100 %)
0 diff
(100 %id)
AI417603 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1186 to 1559 397 to 24   AAA   374/374
(100 %)
1 diff
(99.8 %id)
AA652415 normal prostate, Prostate .e 1187 to 1464 278 to 1       278/278
(100 %)
1 diff
(99.7 %id)
CD247213 embryonic stem cells, WA01, passage 38 .e 1189 to 1561 20 to 391   AAA   372/391
(95 %)
6 diff
(98.5 %id)
AI074911 senescent fibroblast .e 1189 to 1560 377 to 6       372/377
(98 %)
0 diff
(100 %id)
W68270 heart .e 1190 to 1559 370 to 1   fully sequenced,   370/370
(100 %)
2 diff
(99.5 %id)
AA857669 epithelium (cell line), Prostate .e 1191 to 1558 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AW591525 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1191 to 1559 379 to 11   AAA   369/369
(100 %)
2 diff
(99.5 %id)
AI309198 2 pooled tumors (clear cell type), Kidney .e 1196 to 1566 399 to 29   AAA   371/371
(100 %)
12 diff
(96.8 %id)
BF109433 pooled .e 1202 to 1559 368 to 11   AAA   358/358
(100 %)
1 diff
(99.8 %id)
AI090636 heart .e 1203 to 1560 359 to 2       358/359
(99 %)
0 diff
(100 %id)
AW264783 lung, two pooled squamous cell carcinomas .e 1203 to 1561 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
F21090 pectoral muscle (after mastectomy) .e 1208 to 1562 1 to 355       355/355
(100 %)
1 diff
(99.8 %id)
AI024548   .e 1209 to 1562 356 to 3       354/356
(99 %)
0 diff
(100 %id)
AW072593 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .e 1213 to 1559 366 to 20   AAA   347/347
(100 %)
4 diff
(98.9 %id)
AA397435   .e 1216 to 1559 357 to 14   AAA   344/344
(100 %)
0 diff
(100 %id)
AA025421 heart .e 1220 to 1559 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
BM041768 Kidney, Wilms' tumor, cell line .e 1222 to 1512 290 to 1       290/290
(100 %)
5 diff
(98.3 %id)
BI495429 cochlea, ear .e 1225 to 1559 7 to 341   AAA   335/341
(98 %)
0 diff
(100 %id)
BQ028991 Bone, Subchondral Bone .e 1226 to 1561 352 to 17   AAA   336/336
(100 %)
0 diff
(100 %id)
BU739079 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 1227 to 1561 353 to 19   fully sequenced, AAA   335/335
(100 %)
2 diff
(99.5 %id)
AI142537 brain, glioblastoma (pooled) .e 1230 to 1561 355 to 24   AAA   332/332
(100 %)
3 diff
(99.1 %id)
AI697473 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 1230 to 1559 363 to 34   AAA   330/330
(100 %)
5 diff
(98.5 %id)
AW196626 adenocarcinoma, Pancreas .e 1235 to 1560 338 to 13       326/338
(96 %)
0 diff
(100 %id)
AA993621   .e 1237 to 1562 328 to 3       326/328
(99 %)
0 diff
(100 %id)
AW071410 bone marrow, stem cell 34+/38+ .e 1238 to 1554 13 to 330   AAA Submitted on the opposite strand 318/330
(96 %)
6 diff
(98.2 %id)
BE070039 breast .e 1239 to 1528 1 to 291       291/291
(100 %)
7 diff
(97.6 %id)
BE070018 breast .e 1242 to 1532 309 to 21     Submitted on the opposite strand 289/309
(93 %)
0 diff
(100 %id)
BM991495 lung, Metastatic Chondrosarcoma .e 1244 to 1561 336 to 19   AAA   318/318
(100 %)
4 diff
(98.8 %id)
BE858274 brain, glioblastoma (pooled) .e 1245 to 1561 317 to 1       317/317
(100 %)
2 diff
(99.4 %id)
AA809917 germinal center B cell .e 1252 to 1561 349 to 41   AAA   309/309
(100 %)
2 diff
(99.4 %id)
AA447402   .e 1254 to 1564 315 to 5   fully sequenced,   311/315
(98 %)
10 diff
(96.9 %id)
BG057083 anaplastic oligodendroglioma, brain .e 1254 to 1559 325 to 20   AAA   306/306
(100 %)
1 diff
(99.7 %id)
AI436641 ovary, tumor, 5 pooled (see description) .e 1256 to 1561 331 to 26   AAA   306/306
(100 %)
1 diff
(99.7 %id)
AV686764 hepatocellular carcinoma .e 1258 to 1559 6 to 300   AAA   295/300
(98 %)
6 diff
(98.0 %id)
AA159088 Pancreas .e 1264 to 1562 300 to 1   fully sequenced,   300/300
(100 %)
1 diff
(99.7 %id)
CB162065 Liver .e 1276 to 1559 321 to 38   AAA Submitted on the opposite strand 284/284
(100 %)
4 diff
(98.6 %id)
N81056 lung .e 1282 to 1560 279 to 1   fully sequenced,   279/279
(100 %)
1 diff
(99.7 %id)
CU453102 epidermis .e 1294 to 1543 262 to 13     Submitted on the opposite strand 250/273
(91 %)
0 diff
(100 %id)
AA687895 normal prostate, Prostate .e 1301 to 1562 265 to 4       262/265
(98 %)
0 diff
(100 %id)
AA715124 normal prostate, Prostate .e 1301 to 1562 265 to 4       262/265
(98 %)
0 diff
(100 %id)
N74898 lung .e 1304 to 1560 258 to 1       258/258
(100 %)
3 diff
(98.9 %id)
AA872628 germinal center B cell .e 1308 to 1561 273 to 20   AAA   254/256
(99 %)
1 diff
(99.7 %id)
CB135533 Liver .e 1310 to 1559 301 to 52   AAA Submitted on the opposite strand 250/250
(100 %)
1 diff
(99.6 %id)
CF141073 CNCAP(3)T-225 cell line, Prostate .e 1312 to 1559 327 to 80   AAA Submitted on the opposite strand 248/248
(100 %)
1 diff
(99.6 %id)
CA432759 mixed .e 1315 to 1559 263 to 19   AAA   245/245
(100 %)
1 diff
(99.6 %id)
BF090248 nervous_normal .e 1317 to 1558 272 to 31       242/282
(85 %)
0 diff
(100 %id)
Z41069 brain, total brain .e 1317 to 1561 246 to 1       246/246
(100 %)
2 diff
(99.2 %id)
BQ338681 nervous_normal .e 1320 to 1550 230 to 1       230/233
(98 %)
4 diff
(98.3 %id)
AI080044 senescent fibroblast .e 1324 to 1560 245 to 9       237/245
(96 %)
0 diff
(100 %id)
AA894652 Kidney .e 1338 to 1567 230 to 1       230/230
(100 %)
1 diff
(99.6 %id)
AI810883 Prostate .e 1355 to 1559 223 to 19   AAA   205/205
(100 %)
2 diff
(99.1 %id)
F01450 brain, total brain .e 1358 to 1561 204 to 1       204/204
(100 %)
1 diff
(99.6 %id)
FN106405 breast carcinoma .e 1367 to 1462 1 to 91       91/91
(100 %)
7 diff
(92.4 %id)
BF589355 pooled .e 1367 to 1560 194 to 1       194/194
(100 %)
1 diff
(99.5 %id)
AW246868 lung, small cell carcinoma .e 1372 to 1559 201 to 14       188/202
(93 %)
0 diff
(100 %id)
FN169439 breast carcinoma .e 1375 to 1462 1 to 83       83/91
(91 %)
6 diff
(93.5 %id)
AI200359 placenta .e 1397 to 1560 168 to 5       164/168
(97 %)
0 diff
(100 %id)
FN142444 breast carcinoma .e 1448 to 1551 1 to 102       102/102
(100 %)
4 diff
(96.1 %id)
AA918531 Kidney .e 1449 to 1519 71 to 1       71/71
(100 %)
0 diff
(100 %id)
BE787170 large cell carcinoma, lung .f 1 to 796 1 to 787 R36G V37S A38R L39W V40C ... tiling clone,   787/805
(97 %)
21 diff
(97.4 %id)
BG106585 lymph, lymphoma, cell line .g 1 to 737 1 to 730 V45S A46R L47W V48C L49C ... tiling clone,   730/752
(97 %)
24 diff
(96.9 %id)
BF314792 brain, neuroblastoma .g 119 to 932 1 to 803   tiling clone,   803/901
(89 %)
27 diff
(97.1 %id)
BI196781 brain, neuroblastoma .g 119 to 791 1 to 672   tiling clone,   672/673
(99 %)
3 diff
(99.6 %id)
BE260738 brain, neuroblastoma .g 139 to 741 1 to 602       602/603
(99 %)
2 diff
(99.7 %id)
BE313139 brain, neuroblastoma .g 139 to 879 1 to 730       730/811
(90 %)
28 diff
(96.6 %id)
BE261642 brain, neuroblastoma .g 141 to 699 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BM548793 duodenal adenocarcinoma, cell line, small intestine .g 427 to 1077 29 to 680       652/1072
(60 %)
12 diff
(98.9 %id)
BE465883 Kidney .g 604 to 1073 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
T69263 Liver .g 662 to 1045 388 to 1       388/388
(100 %)
18 diff
(95.4 %id)
AW292582   .g 676 to 1073 415 to 18   tiling clone, AAA   398/398
(100 %)
2 diff
(99.5 %id)
BG231779 blood, lymphocyte .g 676 to 1073 398 to 1       398/398
(100 %)
2 diff
(99.5 %id)
AA570104 colon .g 721 to 1069 373 to 26   AAA   348/348
(100 %)
2 diff
(99.5 %id)
BF063990 colon, colon tumor, RER+ .g 730 to 1078 366 to 18   tiling clone, AAA   349/349
(100 %)
3 diff
(99.2 %id)
BG987801 head_neck .g 794 to 931 140 to 3       138/140
(98 %)
0 diff
(100 %id)
BQ428257 leiomyosarcoma, uterus .h 1 to 762 1 to 774 V6A R182X G184R R185X E186G ... tiling clone,   774/917
(84 %)
24 diff
(97.4 %id)
BI763280 pooled colon, kidney, stomach .h 48 to 855 1 to 799 V6A L12S A13L A14R A15H ... tiling clone,   799/799
(100 %)
16 diff
(98.0 %id)
TI_57150112   .h 49 to 855 30 to 827 V6A L12S A13L A14R A15H ...     798/827
(96 %)
17 diff
(98.0 %id)
TI_154172004   .h 69 to 637 48 to 618   tiling clone,   571/604
(94 %)
11 diff
(98.2 %id)
BP192927 brain .i 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
BI857271 breast, mammary adenocarcinoma, cell line .i 120 to 774 1 to 659 F51X R175Q E176G I177N A178C ... tiling clone,   659/707
(93 %)
7 diff
(99.1 %id)
TI_57186943   .i 120 to 774 56 to 714 F51X R175Q E176G I177N A178C ...     659/805
(81 %)
7 diff
(99.2 %id)
BP282980 bone marrow .j-u 1 to 582 1 to 583 exact tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
BI770609 pooled lung and spleen .k 1 to 809 1 to 812 R174E K175E V176R L177C E178W ... tiling clone,   812/812
(100 %)
9 diff
(98.9 %id)
TI_57197797   .k 1 to 794 63 to 864 F51L K65T E72R V73S E74G ...     802/866
(92 %)
31 diff
(96.5 %id)
TI_57183517   .k 1 to 809 31 to 842 R174E K175E V176R L177C E178W ...     812/842
(96 %)
12 diff
(98.6 %id)
BG762372 melanotic melanoma, high MDR (cell line), skin .k 5 to 776 1 to 781 K65N D66R C67L K68Q V69G ...     781/782
(99 %)
14 diff
(98.3 %id)
BI820576 pooled brain, lung, testis .k 8 to 794 1 to 795 F51L K65T E72R V73S E74G ...     795/797
(99 %)
27 diff
(96.7 %id)
BQ062020 lymph, lymphoma, cell line .k 9 to 919 1 to 918 K147X tiling clone,   918/979
(93 %)
11 diff
(98.9 %id)
BI261322 lymph, lymphoma, cell line .k 10 to 499 1 to 481       481/527
(91 %)
17 diff
(96.8 %id)
BE296628 muscle, rhabdomyosarcoma .k 36 to 593 1 to 559       559/559
(100 %)
4 diff
(99.3 %id)
BE297974 muscle, rhabdomyosarcoma .k 37 to 608 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BQ882034 brain, neuroblastoma, cell line .k 63 to 917 1 to 855 exact tiling clone,   855/879
(97 %)
12 diff
(98.7 %id)
BE902883 choriocarcinoma, placenta .k 74 to 816 1 to 735 N36T L37S S38V A39Q A40P ...     735/735
(100 %)
16 diff
(97.9 %id)
CB994340 placenta, pre-eclamptic placenta .l 1 to 782 28 to 814 V62M R108K G128R V129G K130E ... tiling clone,   787/821
(95 %)
23 diff
(97.2 %id)
AA835674 germinal center B cell .l 250 to 709 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
AA748497 germinal center B cell .l 253 to 780 538 to 11 exact tiling clone, AAA   528/528
(100 %)
0 diff
(100 %id)
AA814740 germinal center B cell .l 289 to 709 421 to 1       421/421
(100 %)
0 diff
(100 %id)
BQ011778 placenta .l 321 to 780 475 to 16   AAA   460/460
(100 %)
0 diff
(100 %id)
AW971578   .l 353 to 779 428 to 1     Submitted on the opposite strand 428/428
(100 %)
14 diff
(96.8 %id)
BQ011869 placenta .l 451 to 780 345 to 16   AAA   330/330
(100 %)
0 diff
(100 %id)
AI633901 pooled germ cell tumors .l 530 to 781 254 to 3       252/254
(99 %)
0 diff
(100 %id)
AW235246 pooled germ cell tumors .l 530 to 781 254 to 3       252/254
(99 %)
0 diff
(100 %id)
AW304192 lung, two pooled squamous cell carcinomas .l 579 to 777 199 to 1       199/199
(100 %)
0 diff
(100 %id)
AI628571 Kidney .l 586 to 777 192 to 1       192/192
(100 %)
0 diff
(100 %id)
C01133   .l 680 to 773 1 to 94       94/94
(100 %)
0 diff
(100 %id)
CB961108 Human Placenta, placenta .m-u 1 to 644 21 to 667 G2Q G48R V81A R94Q R103H tiling clone,   647/785
(82 %)
6 diff
(99.3 %id)
CF593889 Human Placenta, placenta .m-u 1 to 873 22 to 902 G2Q G48R V81A R94Q R103H tiling clone,   881/965
(91 %)
6 diff
(99.4 %id)
AA325862 brain, cerebellum .n 1 to 406 1 to 406   tiling clone,   406/406
(100 %)
1 diff
(99.8 %id)
AW964916   .n 2 to 461 1 to 462 R44K     462/525
(88 %)
6 diff
(98.9 %id)
CN291939 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 32 to 616 1 to 583 exact     583/583
(100 %)
1 diff
(99.9 %id)
BE547928 cervical carcinoma cell line, cervix .n 66 to 683 1 to 615       615/828
(74 %)
22 diff
(97.4 %id)
CN291937 embryonic stem cells, cell lines H1, H7, andH9 .n 82 to 664 16 to 598   tiling clone,   581/598
(97 %)
6 diff
(99.0 %id)
AA176522.
matches multiple genes
muscle, skeletal muscle .n 93 to 396 1 to 308     also hits gene skeystobu 308/308
(100 %)
4 diff
(98.8 %id)
AW410747 muscle, rhabdomyosarcoma .o-u 1 to 562 599 to 38 S102P tiling clone, AAA   562/562
(100 %)
1 diff
(99.9 %id)
BG992718 head_neck .o-u 19 to 420 1 to 400       400/414
(96 %)
6 diff
(98.6 %id)
AA101148   .p 1 to 466 1 to 465 G19A E20R S21X R22G N23M ... tiling clone, Submitted on the opposite strand 465/465
(100 %)
7 diff
(98.5 %id)
AA085506   .p 129 to 567 449 to 1   tiling clone, Submitted on the opposite strand 449/450
(99 %)
10 diff
(97.8 %id)
BG015148 placenta_normal .p 265 to 524 10 to 269       260/274
(94 %)
6 diff
(97.9 %id)
AI817539 lymph node, lymphoma, follicular mixed small and largecell .q 1 to 463 1 to 463   tiling clone, Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
BF896925 marrow .q 312 to 732 13 to 428   tiling clone,   416/428
(97 %)
6 diff
(98.6 %id)
BF358794 lung_tumor .q 594 to 1081 487 to 1       487/498
(97 %)
12 diff
(97.6 %id)
BF358798 lung_tumor .q 594 to 1057 465 to 2       464/465
(99 %)
0 diff
(100 %id)
BF370873 prostate_normal .q 594 to 1034 446 to 5       442/446
(99 %)
0 diff
(100 %id)
BF359330 lung_tumor .q 602 to 936 1 to 335       335/335
(100 %)
9 diff
(97.4 %id)
BF370865 prostate_normal .q 603 to 1066 464 to 1       464/464
(100 %)
2 diff
(99.6 %id)
BF358809 lung_tumor .q 613 to 1094 11 to 488       478/497
(96 %)
6 diff
(98.8 %id)
BF370821 prostate_normal .q 632 to 1032 1 to 399       399/399
(100 %)
7 diff
(98.3 %id)
BF354801 head_neck .q 639 to 1090 458 to 8       451/458
(98 %)
0 diff
(100 %id)
BF370818 prostate_normal .q 642 to 1094 5 to 456   tiling clone,   452/471
(95 %)
3 diff
(99.4 %id)
BF359364 lung_tumor .q 647 to 1009 1 to 362       362/362
(100 %)
18 diff
(95.1 %id)
CV412957 prostate_normal .q 660 to 1021 1 to 375       375/375
(100 %)
28 diff
(92.6 %id)
BF370864 prostate_normal .q 905 to 1094 22 to 210       189/219
(86 %)
6 diff
(97.3 %id)
BG742214 skin .q 955 to 1498 1 to 541   tiling clone,   541/883
(61 %)
4 diff
(99.6 %id)
BG119745 adenocarcinoma, cell line, Liver .r-u 1 to 708 1 to 700   tiling clone,   700/972
(72 %)
17 diff
(98.3 %id)
BQ674474 epidermoid carcinoma, cell line, salivary gland .r-u 278 to 886 1 to 609       609/966
(63 %)
19 diff
(98.1 %id)
BG747324 adenocarcinoma cell line, colon .r-u 464 to 1244 1 to 785 F37L L82W C85G     785/787
(99 %)
22 diff
(97.3 %id)
BG747409 adenocarcinoma cell line, colon .r-u 464 to 1245 1 to 781 exact tiling clone,   781/781
(100 %)
20 diff
(97.5 %id)
BG951728 colon .r-u 488 to 807 1 to 317       317/479
(66 %)
8 diff
(98.4 %id)
CK003844 brain/CNS, Human Brain - Cerebellar Cortex .r-u 652 to 1300 1 to 639 F36L F37C A38R E39N T40L ... tiling clone,   639/641
(99 %)
10 diff
(98.5 %id)
BG003911 placenta_normal .r-u 688 to 1206 47 to 578 D2T A8C R9Q T10D W11L ...     532/581
(91 %)
62 diff
(89.4 %id)
BE390805 endometrium, adenocarcinoma cell line, uterus .r-u 693 to 1321 1 to 631 M54I D56G V57C S59L W60S ... tiling clone,   631/703
(89 %)
24 diff
(96.6 %id)
BF836667 head_neck .r-u 775 to 1006 236 to 6     Submitted on the opposite strand 231/241
(95 %)
0 diff
(100 %id)
DN918405   .r-u 784 to 1225 1 to 441       441/441
(100 %)
17 diff
(96.2 %id)
BF516090   .r-u 794 to 1291 1 to 498     Submitted on the opposite strand 498/498
(100 %)
2 diff
(99.6 %id)
H69118 liver and spleen .r-u 802 to 1201 1 to 400     Submitted on the opposite strand 400/400
(100 %)
9 diff
(97.8 %id)
R21972 placenta .r-u 807 to 1189 1 to 396     Submitted on the opposite strand 396/396
(100 %)
15 diff
(96.3 %id)
EL949234 eyeball .r-u 811 to 1306 536 to 41   tiling clone, Submitted on the opposite strand 496/536
(92 %)
0 diff
(100 %id)
AA932064 carcinoid, lung .r-u 811 to 1240 1 to 430     Submitted on the opposite strand 430/430
(100 %)
0 diff
(100 %id)
AA988583 carcinoid, lung .r-u 814 to 1191 1 to 378     Submitted on the opposite strand 378/378
(100 %)
2 diff
(99.5 %id)
FN057820 breast carcinoma .r-u 878 to 977 100 to 1     Submitted on the opposite strand 100/100
(100 %)
0 diff
(100 %id)
BF347935 anaplastic oligodendroglioma with 1p/19qloss, brain .s-u 1 to 757 1 to 756 L12W A13L H14T C15A G16V ... tiling clone,   756/873
(86 %)
41 diff
(95.4 %id)
AW991640 breast_normal Gene C21orf33, variant not shown         Submitted on the opposite strand    
BX363913   Gene C21orf33, variant not shown              
AV649224 corresponding non cancerous liver tissue Gene C21orf33, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV649517 corresponding non cancerous liver tissue Gene C21orf33, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
H85396 eye, retina Gene C21orf33, variant not shown         Suspected internal deletion, this clone was ignored    
BF032598 adenocarcinoma, ovary Gene C21orf33, variant not shown         This clone was ignored    
BF698703 brain, primitive neuroectoderm Gene C21orf33, variant not shown              
BF698658 brain, primitive neuroectoderm Gene C21orf33, variant not shown              
BF795109 lymph, lymphoma, cell line Gene C21orf33, variant not shown         This clone was ignored    
BG253797 adenocarcinoma, cell line, Prostate Gene C21orf33, variant not shown         Suspected internal deletion, this clone was ignored    
BG390134 embryonal carcinoma, cell line, testis Gene C21orf33, variant not shown              
BI763865 pooled colon, kidney, stomach Gene C21orf33, variant not shown         This clone was ignored    
BI911545 leukocyte Gene C21orf33, variant not shown         This clone was ignored    
BM925044 pooled lung and spleen Gene C21orf33, variant not shown         This clone was ignored    
BQ057019 lymph, lymphoma, cell line Gene C21orf33, variant not shown         This clone was ignored    
BQ058249 lymph, lymphoma, cell line Gene C21orf33, variant not shown         This clone was ignored    
BQ926163 large cell carcinoma, lung Gene C21orf33, variant not shown         This clone was ignored    
CV814494 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass Gene C21orf33, variant not shown         This clone was ignored    
TI_57151675   Gene C21orf33, variant not shown         This clone was ignored    
TI_57232892   Gene C21orf33, variant not shown         This clone was ignored    
BM153295 leukopheresis Gene C21orf33, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m-u, .n, .o-u, .p, .q, .r-u, .s-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI